PlainRecalls
FDA Drug Low Class III Terminated

Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, India; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 47152 USA. NDC: 0904-6735-61

Reported: May 20, 2020 Initiated: April 24, 2020 #D-1262-2020

Product Description

Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, India; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 47152 USA. NDC: 0904-6735-61

Reason for Recall

Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
678 cartons
Distribution
AL, FL, IA, NY, OH, TX
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, India; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 47152 USA. NDC: 0904-6735-61. Recalled by The Harvard Drug Group. Units affected: 678 cartons.
Why was this product recalled?
Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 20, 2020. Severity: Low. Recall number: D-1262-2020.